DT Cloud Acquisition Corporation
DYCQR
NASDAQ Global Market0.23
USD
+0.03
- -
DT Cloud Acquisition Corporation
DYCQR
(NASDAQ Global Market)
Recent
price
0.23
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- DT Cloud Acquisition Corporation functions as a special purpose acquisition company, primarily established to complete a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or another similar business combination with an identified entity. The company has recently entered into a definitive agreement for a business combination with Maius Pharmaceutical Co., Ltd., a biopharmaceutical firm specializing in innovative formulations and targeted small-molecule chemical drugs, with a focus on anticancer, autoimmune, and anti-infective medications. This transaction is anticipated to conclude in the initial half of 2025. Nevertheless, DT Cloud Acquisition Corporation recently received notification from Nasdaq regarding its non-compliance with listing requirements, which threatens a suspension of trading on November 21, 2025, pending any appeal. Established in 2022, the company maintains its headquarters in London, United Kingdom, and operates as a subsidiary of DT Cloud Capital Corp.